Skip to main content
logo
Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
14.90
+0.31 (2.09%)
At close: Aug 29, 2025, 4:00 PM
14.61
-0.29 (-1.92%)
After-hours: Aug 29, 2025, 4:14 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
Recombinant Human C1 Esterase Inhibitor
226.91M
Log In
Log In
Log In
Log In
Upgrade
Recombinant Human C1 Esterase Inhibitor Growth
15.98%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2023FY 2022FY 2021FY 2020FY 20192016 - 2018
Period Ending
Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2016 - 2018
United States
221.17M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
16.17%
Log In
Log In
Log In
Log In
Upgrade
Europe and Rest of World
5.74M
Log In
Log In
Log In
Log In
Upgrade
Europe
-
Log In
Log In
Log In
Log In
Upgrade
Europe Growth
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World
-
Log In
Log In
Log In
Log In
Upgrade
Rest of the World Growth
-
Log In
Log In
Log In
Log In
Upgrade